logo
Select company
Select metric
$ -91.26MEarning Before Interest & Taxes (EBIT)
VS
Market
10
Sector
22
Industry
31
History
14
$ 45.78Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -91.26M
3/31/2025$ -87.29M
12/31/2024$ -83.44M
9/30/2024$ -100.53M
6/30/2024$ -91.59M
3/31/2024$ -80.93M
12/31/2023$ -81.14M
9/30/2023$ -60.46M
6/30/2023$ -68.05M
3/31/2023$ -78.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) EBIT stands at $ -23.62M.
  • Over the past 5 years, KORRO BIO INC's average EBIT has been $ -73.69M.
  • The median EBIT for KORRO BIO INC during this period was $ -81.55M
  • KORRO BIO INC reached its highest EBIT over the past 5 years at $ -23.62M.
  • The lowest EBIT recorded by KORRO BIO INC in the same timeframe $ -100.53M

KORRO BIO INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CRBU : CARIBOU BIOSCIENCES INC $ -164.27MACOG : ALPHA COGNITION INC $ -19.92MTCRX : TSCAN THERAPEUTICS INC $ -133.66MTVRD : TVARDI THERAPEUTICS INC $ -13.84MOBIO : ORCHESTRA BIOMED HOLDINGS INC $ -69.66MFATE : FATE THERAPEUTICS INC $ -171.52MCRVO : CERVOMED INC $ -22.61MOVID : OVID THERAPEUTICS INC $ -38.18MCBUS : CIBUS INC $ -241.12MARMP : ARMATA PHARMACEUTICALS INC $ -12.09M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

KRRO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -100.53M

Minimum

Sep 30, 2024

$ -23.62M

Maximum

Sep 30, 2020

$ -73.69M

Average

$ -81.55M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.79M with a standard deviation of $ 130.84M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.79M
median$ 971K
std$ 130.84M